(Press-News.org) New Haven, Conn. – Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.
The treatment uses a microRNA mimic, miR-29, which is delivered to lung tissue intravenously. In mouse models, miR-29 not only blocked pulmonary fibrosis, it reversed fibrosis after several days.
The findings were published Sept. 19 in the journal EMBO Molecular Medicine.
"The mimic, when injected into the blood, goes to the lung and it has a sustained effect. We are very impressed that it can reverse fibrosis, not only prevent it," said Naftali Kaminski, M.D., a professor at Yale School of Medicine and section chief of pulmonary, critical care, and sleep medicine. He is a corresponding author of the study.
The research is a collaboration between Yale and miRagen Therapeutics, a pharmaceutical company based in Boulder, Colo. The company had developed miR-29 previously as a possible therapy for cardiac disease. Kaminski, whose group pioneered research in microRNA in lung fibrosis, saw the potential for use of miR-29 in pulmonary fibrosis, as did Eva van Rooij, the scientist who discovered the role for miR-29 in cardiac fibrosis and is a senior co-author on the paper.
"I'm particularly excited about working with this microRNA," said van Rooij, who now is at the Hubrecht Institute in the Netherlands. "All evidence points to it being a master regulator of fibrosis."
The next step, Kaminski said, will be to begin evaluating miR-29 as a therapeutic for human Idiopathic Pulmonary Fibrosis (IPF). Once considered a rare disease, IPF now affects more than 200,000 people in the United States, where about 30,000 people die from IPF every year. The median survival from diagnosis is 3-5 years, and despite recent promising advances there is no intervention that reverses the disease.
INFORMATION:
Reversing the effects of pulmonary fibrosis
2014-09-22
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Experts provide much-needed policy analysis for clinical integration of next generation sequencing
2014-09-22
HOUSTON – (Sept. 22, 2014) – As genetic sequencing technologies continue to evolve rapidly, becoming part of clinical care, there is a critical need to establish appropriate policies and regulatory frameworks to address potential challenges, legal and ethical experts have said. A special policy issue of the Journal of Law, Medicine & Ethics published online today and edited by experts with the Center for Medical Ethics and Health Policy at Baylor College of Medicine gives policy makers the tools to jumpstart this process.
Experts with the Center for Medical Ethics and ...
Can tapioca replace corn as the main source for starch sweeteners?
2014-09-22
New Rochelle, NY, September 22, 2014—Cassava, also known as tapioca, has large starch-filled roots and can grow at high yields in areas of Africa, Asia, and Latin America where corn and sugarcane are not commonly grown. With the availability of novel enzymes and processes designed to break down tapioca starch into sugars that can then be used to produce sweeteners such as glucose, fructose, or maltose syrup, tapioca may be an ideal alternative to corn, as described in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
Kessler pilot study demonstrates benefits of wellness program for people with MS
2014-09-22
West Orange, NJ. September 22, 2014. Kessler researchers have published a pilot study showing the benefits of a 10-week psychoeducational wellness program in people with multiple sclerosis (MS). Improvements were seen in mood, overall mental health, perceived stress, and pain. "Development and effectiveness of a psychoeducational wellness group for individuals living with MS: Description and outcomes" was epublished ahead of print on September 3 in the International Journal of MS Care (doi: 10.7224/1537-2073.2013-045). The authors are Kimberly Beckwith McGuire, PhD, of ...
Priorities for research on pharmaceutical and personal care products in the environment
2014-09-22
PENSACOLA, Fla. – In 2011 the Society of Environmental Toxicology and Chemistry (SETAC) held a workshop for 45 international experts to identify and prioritize the scientific research needed to understand the risks of pharmaceuticals and personal care products (PPCPs) in the environment. The effort was extended, and results were published in the most recent issue of the Society's international journal, Integrated Environmental Assessment and Management (IEAM). The published work is accompanied by a podcast interviewing the lead author of the study, Murray Rudd from the ...
Wildfires in Khabarovsk Krai, Russia
2014-09-22
Most of the fires captured in this image burn in Khabarovsk Krai, a territory occupying the coastline of the Sea of Okhotsk. Dozens of red hotspots, accompanied by plumes of smoke mark active fires. The smoke, which appears mostly white or grey, blows to the east towards the Sea of Okhotsk. Taiga and tundra are found in the north of this area, swampy forest inhabit the central depression, and deciduous forests are the natural vegetation in the south.
While large wildfires are common in Russia in the summer, the 2014 wildfire season appears to be more intense than usual. ...
New chip promising for tumor-targeting research
2014-09-22
WEST LAFAYETTE, Ind. – Researchers have developed a chip capable of simulating a tumor's "microenvironment" and plan to use the new system to test the effectiveness of nanoparticles and drugs that target cancer.
The new system, called a tumor-microenvironment-on-chip (T-MOC) device, will allow researchers to study the complex environment surrounding tumors and the barriers that prevent the targeted delivery of therapeutic agents, said Bumsoo Han, a Purdue University associate professor of mechanical engineering.
Researchers are trying to perfect "targeted delivery" methods ...
Brainwave test could improve autism diagnosis and classification
2014-09-22
September 22, 2014 – (BRONX, NY) – A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that measuring how fast the brain responds to sights and sounds could help in objectively classifying people on the autism spectrum and may help diagnose the condition earlier. The paper was published today in the online edition of the Journal of Autism and Developmental Disabilities.
The U.S. Centers for Disease Control and Prevention estimates that 1 in 68 children has been identified with an autism spectrum disorder (ASD). The signs and ...
Common diabetes drug associated with risk of low levels of thyroid hormone
2014-09-22
Metformin, a commonly used drug for treating type 2 diabetes, is linked to an increased risk of low thyroid-stimulating hormone (TSH) levels in patients with underactive thyroids (hypothyroidism), according to a study in CMAJ (Canadian Medical Association Journal). Low levels of TSH can cause harm, such as cardiovascular conditions and fractures.
Metformin is used to lower blood glucose levels by reducing glucose production in the liver. However, some previous studies have raised concerns that metformin may lower thyroid-stimulating hormone levels.
Researchers looked ...
University of Chicago neuroscientists challenge long-held understanding of the sense of touch
2014-09-22
Different types of nerves and skin receptors work in concert to produce sensations of touch, University of Chicago neuroscientists argue in a review article published Sept. 22, 2014, in the journal Trends in Neurosciences. Their assertion challenges a long-held principle in the field—that separate groups of nerves and receptors are responsible for distinct components of touch, like texture or shape. They hope to change the way somatosensory neuroscience is taught and how the science of touch is studied.
Sliman Bensmaia, PhD, assistant professor of organismal biology and ...
Variability keeps the body in balance
2014-09-22
Although the heart beats out a very familiar "lub-dub" pattern that speeds up or slows down as our activity increases or decreases, the pattern itself isn't as regular as you might think. In fact, the amount of time between heartbeats can vary even at a "constant" heart rate—and that variability, doctors have found, is a good thing.
Reduced heart rate variability (HRV) has been found to be predictive of a number of illnesses, such as congestive heart failure and inflammation. For athletes, a drop in HRV has also been linked to fatigue and overtraining. However, the underlying ...